Show your heart a little love this Valentine’s Day.
Take the Listen To Your Heart Challenge!
Everyone who completes the challenge by Heart Valve Disease Awareness Day
(February 22) will be entered to win a $50 Amazon gift card.
Published June 21, 2022
On Monday, June 13, the Alliance for Aging Research submitted comments to the Food and Drug Administration (FDA), responding to their draft guidance for industry on creating a Racial and Ethnic Diversity Plan for clinical trials. In the letter, the Alliance commended the FDA on their increased focus on promoting diversity within clinical trials; a necessary goal not just for understanding the efficacy of medical treatments, but also for establishing public trust.
The Alliance recommended that when clinical trial sponsors create a Racial and Ethnic Diversity Plan, they should look to do the following:
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org.